Cell injection aims to halt vision loss in rare eye disease
Disease control
Recruiting now
This study tests the safety of a single injection of jCell, made from retinal cells, in 60 adults with retinitis pigmentosa, a genetic eye disease that causes vision loss. Participants are randomly assigned to get the real injection or a sham procedure. The main goal is to check …
Phase: PHASE2 • Sponsor: jCyte, Inc • Aim: Disease control
Last updated May 04, 2026 16:22 UTC